Nanau RM, Cohen LE, Neuman MG. Risk of Infections of Biological Therapies with Accent on Inflammatory Bowel Disease. J Pharm Pharm Sci [Internet]. 2014 Oct. 30 [cited 2024 Dec. 22];17(4):485-531. Available from: https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/22883